Health, Fitness & Food

In this article LLY NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Companies are increasing access to new blockbuster weight-loss drugs for employees, but size of employer may make a big difference
0 Comments
In this article NES.N-CH Follow your favorite stocksCREATE FREE ACCOUNT The meteoric rise of weight loss drugs means consumers’ nutritional needs are “shifting” which provides new opportunities for food companies, Nestle CEO Mark Schneider told CNBC. Investors were initially concerned about the popularity of GLP-1 drugs such as Wegovy and Ozempic as it was assumed
0 Comments
In this article AZN-GB BMY LLY NVS NOV.N-CH Follow your favorite stocksCREATE FREE ACCOUNT Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a “massive opportunity.” It’s called targeted radiopharmaceuticals. The therapy essentially delivers radiation directly into tumors by
0 Comments
In this article HIMS NVO Follow your favorite stocksCREATE FREE ACCOUNT Products of Hims & Hers displayed. Hims & Hers Digital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections, the company announced Monday. The company, which offers a range of direct-to-consumer treatments for conditions like erectile dysfunction and
0 Comments
In this article SAN-FR NVAX Follow your favorite stocksCREATE FREE ACCOUNT A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022.  Dado Ruvic | Reuters Shares of Novavax jumped as much as 50% on Monday as Wall Street cheered the company’s new multibillion-dollar deal with French drugmaker Sanofi that
0 Comments
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. U.S. stocks were little changed Tuesday as the market digested hotter-than-expected inflation data. April’s producer price index print came in above estimates , further complicating the timeline for Federal Reserve
0 Comments